Clinical application of the rapid pneumococcal urinary antigen test in the treatment of severe pneumonia in children

Huey Fung Cheong, Luo Ping Ger, Ming Ting Wu, Chih Pei Sun, Kai Sheng Hsieh, Yung Ching Liu, Ming Fang Cheng

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background and Purpose: To evaluate the efficacy of the pneumococcal urinary antigen test (PUAT) in severe pediatric pneumonia. Methods: The study enrolled 245 pediatric patients with severe pneumonia. Patients were divided into four groups; groups 1 and 2 received PUAT, while groups 3 and 4 did not. Additionally, PUAT-positive group 1 patients were treated with penicillin, while PUAT-negative patients received ampicillin-sulbactam or cefuroxime. Group 2 patients were treated empirically without following the group 1 protocol. Group 3 patients were treated following the guideline of the Infectious Diseases Society of Taiwan (IDST), and group 4 patients were treated empirically without following the IDST guideline. Treatment was assessed by the duration of fever. Results: Treatment was most effective for group 1 and least effective for group 4. Group 2 treatment was superior to group 3 treatment. Multivariate regression analysis of groups 1 and 2 revealed that the use of PUAT (groups 1 and 2) was associated with superior response in comparison with group 4. Conclusion: Application of PUAT and adequate antimicrobial treatments in the initial stage for pediatric patients with severe pneumonia resulted in improved outcome as assessed by shortening of the duration of fever.

Original languageEnglish
Pages (from-to)41-47
Number of pages7
JournalJournal of Microbiology, Immunology and Infection
Volume41
Issue number1
Publication statusPublished - Feb 2008
Externally publishedYes

Fingerprint

Pneumonia
Antigens
Therapeutics
Pediatrics
Taiwan
Communicable Diseases
Fever
Guidelines
Cefuroxime
Penicillins
Multivariate Analysis
Regression Analysis

Keywords

  • Antigens, bacterial
  • Child
  • Pneumonia, pneumococcal
  • Predictive value of tests
  • Streptococcus pneumoniae

ASJC Scopus subject areas

  • Microbiology (medical)
  • Immunology and Allergy
  • Immunology and Microbiology(all)

Cite this

Clinical application of the rapid pneumococcal urinary antigen test in the treatment of severe pneumonia in children. / Cheong, Huey Fung; Ger, Luo Ping; Wu, Ming Ting; Sun, Chih Pei; Hsieh, Kai Sheng; Liu, Yung Ching; Cheng, Ming Fang.

In: Journal of Microbiology, Immunology and Infection, Vol. 41, No. 1, 02.2008, p. 41-47.

Research output: Contribution to journalArticle

Cheong, Huey Fung ; Ger, Luo Ping ; Wu, Ming Ting ; Sun, Chih Pei ; Hsieh, Kai Sheng ; Liu, Yung Ching ; Cheng, Ming Fang. / Clinical application of the rapid pneumococcal urinary antigen test in the treatment of severe pneumonia in children. In: Journal of Microbiology, Immunology and Infection. 2008 ; Vol. 41, No. 1. pp. 41-47.
@article{3686dd4e53844be0ac746987ad418554,
title = "Clinical application of the rapid pneumococcal urinary antigen test in the treatment of severe pneumonia in children",
abstract = "Background and Purpose: To evaluate the efficacy of the pneumococcal urinary antigen test (PUAT) in severe pediatric pneumonia. Methods: The study enrolled 245 pediatric patients with severe pneumonia. Patients were divided into four groups; groups 1 and 2 received PUAT, while groups 3 and 4 did not. Additionally, PUAT-positive group 1 patients were treated with penicillin, while PUAT-negative patients received ampicillin-sulbactam or cefuroxime. Group 2 patients were treated empirically without following the group 1 protocol. Group 3 patients were treated following the guideline of the Infectious Diseases Society of Taiwan (IDST), and group 4 patients were treated empirically without following the IDST guideline. Treatment was assessed by the duration of fever. Results: Treatment was most effective for group 1 and least effective for group 4. Group 2 treatment was superior to group 3 treatment. Multivariate regression analysis of groups 1 and 2 revealed that the use of PUAT (groups 1 and 2) was associated with superior response in comparison with group 4. Conclusion: Application of PUAT and adequate antimicrobial treatments in the initial stage for pediatric patients with severe pneumonia resulted in improved outcome as assessed by shortening of the duration of fever.",
keywords = "Antigens, bacterial, Child, Pneumonia, pneumococcal, Predictive value of tests, Streptococcus pneumoniae",
author = "Cheong, {Huey Fung} and Ger, {Luo Ping} and Wu, {Ming Ting} and Sun, {Chih Pei} and Hsieh, {Kai Sheng} and Liu, {Yung Ching} and Cheng, {Ming Fang}",
year = "2008",
month = "2",
language = "English",
volume = "41",
pages = "41--47",
journal = "Journal of Microbiology, Immunology and Infection",
issn = "0253-2662",
publisher = "Elsevier Taiwan LLC",
number = "1",

}

TY - JOUR

T1 - Clinical application of the rapid pneumococcal urinary antigen test in the treatment of severe pneumonia in children

AU - Cheong, Huey Fung

AU - Ger, Luo Ping

AU - Wu, Ming Ting

AU - Sun, Chih Pei

AU - Hsieh, Kai Sheng

AU - Liu, Yung Ching

AU - Cheng, Ming Fang

PY - 2008/2

Y1 - 2008/2

N2 - Background and Purpose: To evaluate the efficacy of the pneumococcal urinary antigen test (PUAT) in severe pediatric pneumonia. Methods: The study enrolled 245 pediatric patients with severe pneumonia. Patients were divided into four groups; groups 1 and 2 received PUAT, while groups 3 and 4 did not. Additionally, PUAT-positive group 1 patients were treated with penicillin, while PUAT-negative patients received ampicillin-sulbactam or cefuroxime. Group 2 patients were treated empirically without following the group 1 protocol. Group 3 patients were treated following the guideline of the Infectious Diseases Society of Taiwan (IDST), and group 4 patients were treated empirically without following the IDST guideline. Treatment was assessed by the duration of fever. Results: Treatment was most effective for group 1 and least effective for group 4. Group 2 treatment was superior to group 3 treatment. Multivariate regression analysis of groups 1 and 2 revealed that the use of PUAT (groups 1 and 2) was associated with superior response in comparison with group 4. Conclusion: Application of PUAT and adequate antimicrobial treatments in the initial stage for pediatric patients with severe pneumonia resulted in improved outcome as assessed by shortening of the duration of fever.

AB - Background and Purpose: To evaluate the efficacy of the pneumococcal urinary antigen test (PUAT) in severe pediatric pneumonia. Methods: The study enrolled 245 pediatric patients with severe pneumonia. Patients were divided into four groups; groups 1 and 2 received PUAT, while groups 3 and 4 did not. Additionally, PUAT-positive group 1 patients were treated with penicillin, while PUAT-negative patients received ampicillin-sulbactam or cefuroxime. Group 2 patients were treated empirically without following the group 1 protocol. Group 3 patients were treated following the guideline of the Infectious Diseases Society of Taiwan (IDST), and group 4 patients were treated empirically without following the IDST guideline. Treatment was assessed by the duration of fever. Results: Treatment was most effective for group 1 and least effective for group 4. Group 2 treatment was superior to group 3 treatment. Multivariate regression analysis of groups 1 and 2 revealed that the use of PUAT (groups 1 and 2) was associated with superior response in comparison with group 4. Conclusion: Application of PUAT and adequate antimicrobial treatments in the initial stage for pediatric patients with severe pneumonia resulted in improved outcome as assessed by shortening of the duration of fever.

KW - Antigens, bacterial

KW - Child

KW - Pneumonia, pneumococcal

KW - Predictive value of tests

KW - Streptococcus pneumoniae

UR - http://www.scopus.com/inward/record.url?scp=44849135570&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44849135570&partnerID=8YFLogxK

M3 - Article

VL - 41

SP - 41

EP - 47

JO - Journal of Microbiology, Immunology and Infection

JF - Journal of Microbiology, Immunology and Infection

SN - 0253-2662

IS - 1

ER -